ABSTRACT
The erythropoietic system plays a major role in tissue oxygenation because the erythrocytes are the primary carriers of oxygen in the form of oxyhemoglobin. Therefore, clinical entities such as abnormal hemoglobins, polycythemia, anemia, and significant changes in blood volume frequently produce alterations in various respiratory functions. The pulmonary manifestations can vary from mild respiratory illness to life-threatening emergencies with high mortality rates. Among the hemoglobinopathies, sickle cell disease is clinically the most important and commonly associated with serious pulmonary consequences, including acute chest syndrome, pneumonia, infarction due to in situ thrombosis, bone marrow fat embolism of pulmonary vasculature, bone marrow infarction, pulmonary hypertension, and other abnormalities. Hemoglobinopathies with high and low affinity for oxygen and other abnormal hemoglobinopathies occasionally cause clinically significant respiratory complications by interfering with normal tissue oxygenation. Acquired methemoglobinemia can cause alarming cyanosis and medical emergency. Erythrocyte disorders are associated with pulmonary complications, including pulmonary hypertension, alveolar fibrosis, and pulmonary dysfunction. Coagulation disorders, both the inherited and acquired types, have the potential to affect the respiratory system in the form of hemorrhage from the airways, lung parenchyma, or pulmonary hypertension. The following paragraphs describe the common pulmonary complications and manifestations associated with hemoglobinopathies, erythrocyte disorders, and coagulation abnormalities.
KEYWORDS
Hemoglobinopathies - sickle cell disease - acute chest syndrome - thalassemia - coagulopathy - erythrocyte disorder - hemolytic anemia - stomatocytosis - methemoglobinemia - cyanosis - high-affinity hemoglobin - low-affinity hemoglobin - disseminated intravascular coagulation - paroxysmal nocturnal hemoglobinuria
REFERENCES
-
1 Saunthararajah Y, Vichinsky E P, Embury S H. Sickle cell disease. In: Hoffman RH Hematology: Basic Principles and Practice. 4th ed. Philedelphia, PA; Elsevier 2005: 605-644
-
2
Bonds D R.
Three decades of innovation in the management of sickle cell disease: the road to understanding the sickle cell disease clinical phenotype.
Blood Rev.
2005;
19
99-110
-
3
Bunn H F.
Pathogenesis and treatment of sickle cell disease.
N Engl J Med.
1997;
337
762-769
-
4
Lane P A.
Sickle cell disease.
Pediatr Clin North Am.
1996;
43
639-664
-
5
Stuart M J, Nagel R L.
Sickle-cell disease.
Lancet.
2004;
364
1343-1360
-
6
Siddiqui A K, Ahmed S.
Pulmonary manifestations of sickle cell disease.
Postgrad Med J.
2003;
79
384-390
-
7
Platt O S, Brambilla D J, Rosse W F et al..
Mortality in sickle cell disease: life expectancy and risk factors for early death.
N Engl J Med.
1994;
330
1639-1644
-
8
Vichinsky E P.
Comprehensive care in sickle cell disease: its impact on morbidity and mortality.
Semin Hematol.
1991;
28
220-226
-
9
Hebbel R P, Osarogiagbon R, Kaul D.
The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
Microcirculation.
2004;
11
129-151
-
10
Hebbel R P, Vercellotti G M.
The endothelial biology of sickle cell disease.
J Lab Clin Med.
1997;
129
288-293
-
11 Chien S, Usami S, Skalak R. Blood flow in small tubes. In: Renkin EM, Michel CC, Geiger SR Handbook of Physiology. Bethesda, MD; American Physiological Society 1993: 217-229
-
12
Aquino S L, Gamsu G, Fahy J V et al..
Chronic pulmonary disorders in sickle cell disease: findings at thin-section CT.
Radiology.
1994;
193
807-811
-
13
Emre U, Miller S T, Rao S P, Rao M.
Alveolar-arterial oxygen gradient in acute chest syndrome of sickle cell disease.
J Pediatr.
1993;
123
272-275
-
14
Poncz M, Kane E, Gill F M.
Acute chest syndrome in sickle cell disease: etiology and clinical correlates.
J Pediatr.
1985;
107
861-866
-
15
Charache S, Scott J C, Charache P.
“Acute chest syndrome” in adults with sickle cell anemia: microbiology, treatment, and prevention.
Arch Intern Med.
1979;
139
67-69
-
16
Castro O, Brambilla D J, Thorington B et al..
The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.
Blood.
1994;
84
643-649
-
17
Vichinsky E P, Neumayr L D, Earles A N et al..
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.
N Engl J Med.
2000;
342
1855-1865
-
18
Martin L, Buonomo C.
Acute chest syndrome of sickle cell disease: radiographic and clinical analysis of 70 cases.
Pediatr Radiol.
1997;
27
637-641
-
19
Platt O S.
The acute chest syndrome of sickle cell disease.
N Engl J Med.
2000;
342
1904-1907
-
20
Comber J T, Lopez B L.
Evaluation of pulse oximetry in sickle cell anemia patients presenting to the emergency department in acute vasoocclusive crisis.
Am J Emerg Med.
1996;
14
16-18
-
21
Bellet P S, Kalinyak K A, Shukla R, Gelfand M J, Rucknagel D L.
Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases.
N Engl J Med.
1995;
333
699-703
-
22
Gelfand M J, Daya S A, Rucknagel D L, Kalinyak K A, Paltiel H J.
Simultaneous occurrence of rib infarction and pulmonary infiltrates in sickle cell disease patients with acute chest syndrome.
J Nucl Med.
1993;
34
614-618
-
23
Babiker M A, Obeid H A, Ashong E F.
Acute reversible pulmonary ischemia: a cause of the acute chest syndrome in sickle cell disease.
Clin Pediatr (Phila).
1985;
24
716-718
-
24
Buchanan I D, Woodward M, Reed G W.
Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Pediatr Blood Cancer.
2005;
45
716-724
-
25
Rucknagel D L, Kalinyak K A, Gelfand M J.
Rib infarcts and acute chest syndrome in sickle cell diseases.
Lancet.
1991;
337
831-833
-
26
Salzman S H.
Does splinting from thoracic bone ischemia and infarction contribute to the acute chest syndrome in sickle cell disease?.
Chest.
2002;
122
6-9
-
27
Sprinkle R H, Cole T, Smith S, Buchanan G R.
Acute chest syndrome in children with sickle cell disease: a retrospective analysis of 100 hospitalized cases.
Am J Pediatr Hematol Oncol.
1986;
8
105-110
-
28
Bhalla M, Abboud M R, McLoud T C et al..
Acute chest syndrome in sickle cell disease: CT evidence of microvascular occlusion.
Radiology.
1993;
187
45-49
-
29
Walker B K, Ballas S K, Burka E R.
The diagnosis of pulmonary thromboembolism in sickle cell disease.
Am J Hematol.
1979;
7
219-232
-
30
Kaur N, Motwani B, Sivasubramaniam D et al..
Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease.
Am J Hematol.
2004;
77
407-409
-
31
Feldman L, Gross R, Garon J et al..
Sickle cell patient with an acute chest syndrome and a negative chest x-ray: potential role of the ventilation and perfusion (V/Q) lung scan.
Am J Hematol.
2003;
74
214-215
-
32
Noto H.
Hemoglobin SC disease presenting as acute chest syndrome with ventilation-perfusion mismatches.
Respiration.
1999;
66
73-77
-
33
Pearson H A, Spencer R P, Cornelius E A.
Functional asplenia in sickle-cell anemia.
N Engl J Med.
1969;
281
923-926
-
34
Winkelstein J A, Drachman R H.
Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.
N Engl J Med.
1968;
279
459-466
-
35
Winkelstein J A.
Pneumococcal infections in sickle cell disease.
J Pediatr.
1977;
91
521-522
-
36
Greene J R, Polk O D, Castro O.
Fulminant pneumococcal sepsis in an adult with sickle-cell anemia.
N Engl J Med.
1984;
311
674
-
37
Olopoenia L, Frederick W, Greaves W, Adams R, Addo F E, Castro O.
Pneumococcal sepsis and meningitis in adults with sickle cell disease.
South Med J.
1990;
83
1002-1004
-
38
Barrett-Connor E.
Bacterial infection and sickle cell anemia: an analysis of 250 infections in 166 patients and a review of the literature.
Medicine (Baltimore).
1971;
50
97-112
-
39
Zarkowsky H S, Gallagher D, Gill F M et al..
Bacteremia in sickle hemoglobinopathies.
J Pediatr.
1986;
109
579-585
-
40
Dagan R, Melamed R, Zamir O, Leroy O.
Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
Pediatr Infect Dis J.
1997;
16
1053-1059
-
41
Wong W Y, Powars D R, Chan L, Hiti A, Johnson C, Overturf G.
Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience.
Am J Hematol.
1992;
39
176-182
-
42
Falletta J M, Woods G M, Verter J I et al..
Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.
J Pediatr.
1995;
127
685-690
-
43
Gaston M H, Verter J I, Woods G et al..
Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial.
N Engl J Med.
1986;
314
1593-1599
-
44
Hongeng S, Wilimas J A, Harris S, Day S W, Wang W C.
Recurrent Streptococcus pneumoniae sepsis in children with sickle cell disease.
J Pediatr.
1997;
130
814-816
-
45
Wang W C, Wong W Y, Rogers Z R, Wilimas J A, Buchanan G R, Powars D R.
Antibiotic-resistant pneumococcal infection in children with sickle cell disease in the United States.
J Pediatr Hematol Oncol.
1996;
18
140-144
-
46
Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B.
Newborn screening for sickle cell disease: effect on mortality.
Pediatrics.
1988;
81
749-755
-
47
Ward J, Smith A L.
Hemophilus influenzae bacteremia in children with sickle cell disease.
J Pediatr.
1976;
88
261-263
-
48
Marcinak J F, Frank A L, Labotka R L et al..
Immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases.
J Pediatr.
1991;
118
69-71
-
49
Miller S T, Hammerschlag M R, Chirgwin K et al..
Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease.
J Pediatr.
1991;
118
30-33
-
50
Kirkpatrick M B, Haynes Jr J, Bass Jr J B.
Results of bronchoscopically obtained lower airway cultures from adult sickle cell disease patients with the acute chest syndrome.
Am J Med.
1991;
90
206-210
-
51
Bowman S J.
Pulmonary tuberculosis precipitating the nephrotic syndrome in a patient with sickle cell disease.
Nephron.
1991;
57
236
-
52
Ryan T J, O'Connor T F, Mc C P, Katz S.
Sickle cell trait and tuberculosis.
Am Rev Respir Dis.
1960;
81
546-549
-
53
Chan O, Loveday E.
Case report: widespread tuberculosis in sickle cell disease.
Clin Radiol.
1992;
45
211-214
-
54
Lowenthal E A, Wells A, Emanuel P D, Player R, Prchal J T.
Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and review.
Am J Hematol.
1996;
51
207-213
-
55
Saarinen U M, Chorba T L, Tattersall P et al..
Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia.
Blood.
1986;
67
1411-1417
-
56
Young N.
Hematologic and hematopoietic consequences of B19 parvovirus infection.
Semin Hematol.
1988;
25
159-172
-
57
Vichinsky E, Williams R, Das M et al..
Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia.
Blood.
1994;
83
3107-3112
-
58
Godeau B, Schaeffer A, Bachir D et al..
Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism.
Am J Respir Crit Care Med.
1996;
153
1691-1696
-
59
Vichinsky E, Styles L.
Pulmonary complications.
Hematol Oncol Clin North Am.
1996;
10
1275-1287
-
60
Williams R A.
Lipid-laden alveolar macrophages may indicate either aspiration pneumonia or sickle cell acute chest syndrome associated with pulmonary fat embolism.
Arch Pathol Lab Med.
1995;
119
772
-
61
Barrett-Connor E.
Acute pulmonary disease and sickle cell anemia.
Am Rev Respir Dis.
1971;
104
159-165
-
62 Charache S, Lubin B, Reid C. Management and Therapy of Sickle Cell Disease. NIH publication no. 89-2117. Washington, DC; National Institutes of Health 1989
-
63
Gillett D S, Gunning K E, Sawicka E H, Bellingham A J, Ware R J.
Life threatening sickle chest syndrome treated with extracorporeal membrane oxygenation.
Br Med J (Clin Res Ed).
1987;
294
81-82
-
64
Godeau B, Dhainaut J F, Bachir D, Galacteros F.
Pulmonary fat embolism after prostaglandin infusion in sickle cell disease with fatal outcome despite exchange blood transfusion.
Am J Hematol.
1993;
43
330-331
-
65
Bargoma E M, Mitsuyoshi J K, Larkin S K, Styles L A, Kuypers F A, Test S T.
Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome.
Blood.
2005;
105
3384-3385
-
66
Kuypers F A, Styles L A.
The role of secretory phospholipase A2 in acute chest syndrome.
Cell Mol Biol (Noisy-le-grand).
2004;
50
87-94
-
67
Styles L A, Schalkwijk C G, Aarsman A J, Vichinsky E P, Lubin B H, Kuypers F A.
Phospholipase A2 levels in acute chest syndrome of sickle cell disease.
Blood.
1996;
87
2573-2578
-
68
Styles L A, Aarsman A J, Vichinsky E P, Kuypers F A.
Secretory phospholipase A(2) predicts impending acute chest syndrome in sickle cell disease.
Blood.
2000;
96
3276-3278
-
69
Ataga K I, Sood N, De Gent G et al..
Pulmonary hypertension in sickle cell disease.
Am J Med.
2004;
117
665-669
-
70
Castro O, Hoque M, Brown B D.
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival.
Blood.
2003;
101
1257-1261
-
71
Castro O.
Systemic fat embolism and pulmonary hypertension in sickle cell disease.
Hematol Oncol Clin North Am.
1996;
10
1289-1303
-
72
Powars D, Weidman J A, Odom-Maryon T, Niland J C, Johnson C.
Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
Medicine (Baltimore).
1988;
67
66-76
-
73
Haque A K, Gokhale S, Rampy B A, Adegboyega P, Duarte A, Saldana M J.
Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases.
Hum Pathol.
2002;
33
1037-1043
-
74
Gladwin M T, Sachdev V, Jison M L et al..
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
N Engl J Med.
2004;
350
886-895
-
75
Lin E E, Rodgers G P, Gladwin M T.
Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.
Curr Hematol Rep.
2005;
4
117-125
-
76
Machado R F, Gladwin M T.
Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
Br J Haematol.
2005;
129
449-464
-
77
Morris C R, Morris Jr S M, Hagar W et al..
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?.
Am J Respir Crit Care Med.
2003;
168
63-69
-
78
Hammond T G, Mosesson M W.
Fatal small-bowel necrosis and pulmonary hypertension in sickle cell disease.
Arch Intern Med.
1989;
149
447-448
-
79
Haupt H M, Moore G W, Bauer T W, Hutchins G M.
The lung in sickle cell disease.
Chest.
1982;
81
332-337
-
80
Oppenheimer E H, Esterly J R.
Pulmonary changes in sickle cell disease.
Am Rev Respir Dis.
1971;
103
858-859
-
81
Rahimtoola S, Good C J, Davies P D.
Pulmonary infarction in disorders associated with the sickle cell trait.
Thorax.
1960;
15
320-324
-
82
Israel R H, Salipante J S.
Pulmonary infarction in sickle cell trait.
Am J Med.
1979;
66
867-869
-
83
Karayalcin G, Imran M, Rosner F.
“Blister cells”: association with pregnancy, sickle cell disease, and pulmonary infarction.
JAMA.
1972;
219
1727-1729
-
84
Maggi J C, Nussbaum E.
Massive pulmonary infarction in sickle cell anemia.
Pediatr Emerg Care.
1987;
3
30-32
-
85
Sugarman J, Samuelson W M, Wilkinson Jr R H, Rosse W F.
Pulmonary embolism and splenic infarction in a patient with sickle cell trait.
Am J Hematol.
1990;
33
279-281
-
86
Eckardt P, Raez L E, Restrepo A, Temple J D.
Pulmonary bone marrow embolism in sickle cell disease.
South Med J.
1999;
92
245-247
-
87
Girard W.
Case report: postoperative pulmonary edema and sickle cell crisis.
Clin Notes Respir Dis.
1979;
17
13-14
-
88
Haynes Jr J, Allison R C.
Pulmonary edema: complication in the management of sickle cell pain crisis.
Am J Med.
1986;
80
833-840
-
89
Wall M A, Platt O S, Strieder D J.
Lung function in children with sickle cell anemia.
Am Rev Respir Dis.
1979;
120
210-214
-
90
Collins F S, Orringer E P.
Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies.
Am J Med.
1982;
73
814-821
-
91
Leong M A, Dampier C, Varlotta L, Allen J L.
Airway hyperreactivity in children with sickle cell disease.
J Pediatr.
1997;
131
278-283
-
92
Bryant R.
Asthma in the pediatric sickle cell patient with acute chest syndrome.
J Pediatr Health Care.
2005;
19
157-162
-
93
Knight-Madden J M, Forrester T S, Lewis N A, Greenough A.
Asthma in children with sickle cell disease and its association with acute chest syndrome.
Thorax.
2005;
60
206-210
-
94
Nordness M E, Lynn J, Zacharisen M C, Scott P J, Kelly K J.
Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease.
Clin Mol Allergy.
2005;
3
2
-
95
Samuels M P, Stebbens V A, Davies S C, Picton-Jones E, Southall D P.
Sleep-related upper airway obstruction and hypoxaemia in sickle cell disease.
Arch Dis Child.
1992;
67
925-929
-
96
Davies S C, Stebbens V A, Samuels M P, Southall D P.
Upper airways obstruction and cerebrovascular accident in children with sickle cell anaemia.
Lancet.
1989;
2
283-284
-
97
Sidman J D, Fry T L.
Exacerbation of sickle cell disease by obstructive sleep apnea.
Arch Otolaryngol Head Neck Surg.
1988;
114
916-917
-
98
Miller G J, Serjeant G R, Saunders M J, Richardson C, Gilson R J.
Interpretation of lung function tests in the sickle-cell haemoglobinopathies.
Thorax.
1978;
33
85-88
-
99
Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G.
Pulmonary function in sickle cell disease with or without acute chest syndrome.
Eur Respir J.
1998;
12
1124-1129
-
100
Hijazi Z, Onadeko B O, Khadadah M, Haider M Z, Adekile A D, Al-Habashi H.
Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Int J Clin Pract.
2005;
59
163-167
-
101
Sylvester K P, Patey R A, Milligan P et al..
Pulmonary function abnormalities in children with sickle cell disease.
Thorax.
2004;
59
67-70
-
102
Pianosi P, D'Souza S J, Charge T D, Esseltine D E, Coates A L.
Pulmonary function abnormalities in childhood sickle cell disease.
J Pediatr.
1993;
122
366-371
-
103
Femi-Pearse D, Gazioglu K M, Yu P N.
Pulmonary function studies in sickle cell disease.
J Appl Physiol.
1970;
28
574-577
-
104
Villa M P, Rotili P L, Santamaria F et al..
Physical performance in patients with thalassemia before and after transfusion.
Pediatr Pulmonol.
1996;
21
367-372
-
105
Youngchaiyud P, Suthamsmai T, Fucharoen S, Udompanich V, Pushpakom R, Wasi P.
Lung function tests in splenectomized beta-thalassemia/Hb E patients.
Birth Defects Orig Artic Ser.
1987;
23
361-370
-
106
Santamaria F, Villa M P, Ronchetti R.
Pulmonary function abnormalities in thalassemia major.
Am J Respir Crit Care Med.
1995;
151
919
-
107
Piatti G, Allegra L, Ambrosetti U, Cappellini M D, Turati F, Fiorelli G.
Beta-thalassemia and pulmonary function.
Haematologica.
1999;
84
804-808
-
108
Keens T G, O'Neal M H, Ortega J A, Hyman C B, Platzker A C.
Pulmonary function abnormalities in thalassemia patients on a hypertransfusion program.
Pediatrics.
1980;
65
1013-1017
-
109
Hoyt R W, Scarpa N, Wilmott R W, Cohen A, Schwartz E.
Pulmonary function abnormalities in homozygous beta-thalassemia.
J Pediatr.
1986;
109
452-455
-
110
Ooi G C, Khong P L, Chan G C et al..
Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.
Br J Haematol.
2004;
124
385-390
-
111
Grisaru D, Rachmilewitz E A, Mosseri M et al..
Cardiopulmonary assessment in beta-thalassemia major.
Chest.
1990;
98
1138-1142
-
112
Factor J M, Pottipati S R, Rappoport I, Rosner I K, Lesser M L, Giardina P J.
Pulmonary function abnormalities in thalassemia major and the role of iron overload.
Am J Respir Crit Care Med.
1994;
149
1570-1574
-
113
Cooper D M, Hyman C B, Weiler-Ravell D, Noble N A, Agness C L, Wasserman K.
Gas exchange during exercise in children with thalassemia major and Diamond-Blackfan anemia.
Pediatr Res.
1985;
19
1215-1219
-
114
Freedman M H, Grisaru D, Olivieri N, MacLusky I, Thorner P S.
Pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine infusions.
Am J Dis Child.
1990;
144
565-569
-
115
Gallant T, Freedman M H, Vellend H, Francombe W H.
Yersinia sepsis in patients with iron overload treated with deferoxamine.
N Engl J Med.
1986;
314
1643
-
116
Fucharoen S, Youngchaiyud P, Wasi P.
Hypoxaemia and the effect of aspirin in thalassaemia.
Southeast Asian J Trop Med Public Health.
1981;
12
90-93
-
117
Rostagno C, Prisco D, Abbate R, Poggesi L.
Pulmonary hypertension associated with long-standing thrombocytosis.
Chest.
1991;
99
1303-1305
-
118
Eldor A, Durst R, Hy-Am E et al..
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.
Br J Haematol.
1999;
107
739-746
-
119
Cappellini M D, Robbiolo L, Bottasso B M, Coppola R, Fiorelli G, Mannucci A P.
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.
Br J Haematol.
2000;
111
467-473
-
120
Percy M J, McFerran N V, Lappin T R.
Disorders of oxidised haemoglobin.
Blood Rev.
2005;
10
61-68
-
121
Dinneen S F, Mohr D N, Fairbanks V F.
Methemoglobinemia from topically applied anesthetic spray.
Mayo Clin Proc.
1994;
69
886-888
-
122
Rosen P J, Johnson C, McGehee W G, Beutler E.
Failure of methylene blue treatment in toxic methemoglobinemia: association with glucose-6-phosphate dehydrogenase deficiency.
Ann Intern Med.
1971;
75
83-86
-
123
Bogdan C J, Strauss M, Ratnoff O D.
Airway obstruction in hemophilia (factor VIII deficiency): a 28-year institutional review.
Laryngoscope.
1994;
104
789-794
-
124
Schulman S, Johnsson H, Blomqvist S.
Pulmonary hypertension in hemophilia.
Ann Intern Med.
1988;
109
759-760
-
125
Goldsmith Jr G H, Baily R G, Brettler D B et al..
Primary pulmonary hypertension in patients with classic hemophilia.
Ann Intern Med.
1988;
108
797-799
-
126
Takeda R, Mabuchi H.
A massive pulmonary hemorrhage resulting in cavitation occurring in a case of hemophilia A associated with diabetes mellitus.
South Med J.
1974;
67
869-873
-
127
Robboy S J, Minna J D, Colman R W, Birndorf N I, Lopas H.
Pulmonary hemorrhage syndrome as a manifestation of disseminated intravascular coagulation: analysis of ten cases.
Chest.
1973;
63
718-721
-
128
Thomson F J, Benbow E W, McMahon R F, Cheshire C M.
Pulmonary infarction, myocardial infarction, and acute disseminated intravascular coagulation.
J Clin Pathol.
1991;
44
1034-1036
-
129
Katsumura Y, Ohtsubo K.
Incidence of pulmonary thromboembolism, infarction and haemorrhage in disseminated intravascular coagulation: a necroscopic analysis.
Thorax.
1995;
50
160-164
-
130
Stahl R L, Javid J P, Lackner H.
Unrecognized pulmonary embolism presenting as disseminated intravascular coagulation.
Am J Med.
1984;
76
772-778
-
131
Pesola G R, Carlon G C.
Pulmonary embolus-induced disseminated intravascular coagulation.
Crit Care Med.
1987;
15
983-984
-
132
Jubelirer S J.
Primary pulmonary hypertension: its association with microangiopathic hemolytic anemia and thrombocytopenia.
Arch Intern Med.
1991;
151
1221-1223
-
133
Stuard I D, Heusinkveld R S, Moss A J.
Microangiopathic hemolytic anemia and thrombocytopenia in primary pulmonary hypertension.
N Engl J Med.
1972;
287
869-870
-
134
Mustafa M H, Mispireta L A, Pierce L E.
Occult pulmonary embolism presenting with thrombocytopenia and elevated fibrin split products.
Am J Med.
1989;
86
490-491
-
135 Warkentin T E. Pseudo-heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A Heparin-Induced Thrombocytopenia. 3rd ed. New York; Marcel Dekker 2004: 313
-
136
Warkentin T E, Levine M N, Hirsh J et al..
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.
N Engl J Med.
1995;
332
1330-1335
-
137
Badmanaban B, Sachithanandan A, Hunter I, Graham A, Sarsam M.
Massive pulmonary embolism due to late-onset heparin-induced thrombocytopenia following coronary artery bypass graft surgery: successful treatment with lepirudin.
J Card Surg.
2003;
18
316-318
-
138
Betrosian A P, Theodossiades G, Lambroulis G et al..
Heparin-induced thrombocytopenia with pulmonary embolism and disseminated intravascular coagulation associated with low-molecular-weight heparin.
Am J Med Sci.
2003;
325
45-47
-
139
Tefferi A, Solberg L A, Silverstein M N.
A clinical update in polycythemia vera and essential thrombocythemia.
Am J Med.
2000;
109
141-149
-
140
Berlin N I.
Polycythemia vera: diagnosis and treatment 2002.
Expert Rev Anticancer Ther.
2002;
2
330-336
-
141
Nand S, Orfei E.
Pulmonary hypertension in polycythemia vera.
Am J Hematol.
1994;
47
242-244
-
142
Ruggeri M, Tosetto A, Castaman G, Rodeghiero F.
Pulmonary embolism after pregnancy in a patient with polycythemia vera.
Am J Hematol.
2001;
67
216-217
-
143
Scharenberg C, Riera R, Gorg C, Walthers E M, Barth P J.
Thrombotic pulmonary arteriopathy in polycythemia vera.
Pathol Res Pract.
1999;
195
653-656
-
144
Ishihara S, Yasuhara H, Ogawa S, Muto T.
Successful surgical treatment for spontaneous retroperitoneal hematoma in polycythemia vera: report of a case.
Surg Today.
2000;
30
199-201
-
145
Dingli D, Utz J P, Krowka M J, Oberg A L, Tefferi A.
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
Chest.
2001;
120
801-808
-
146
Marvin K S, Spellberg R D.
Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia.
Chest.
1993;
103
642-644
-
147
Murata M, Kuroda T, Nakajima K, Fujikawa H, Shimada K.
Primary pulmonary hypertension with severe systemic hypertension, Raynaud's phenomenon and relative polycythemia.
Intern Med.
2001;
40
905-910
-
148
Burgess J H, Bishop J M.
Pulmonary diffusing capacity and its subdivisions in polycythemia vera.
J Clin Invest.
1963;
42
997-1006
-
149
Herbert S J, Weill H, Stuckey W J, Urner C, Gonzales E, Ziskind M M.
Pulmonary diffusing capacity in polycythemic states before and after phlebotomy.
Dis Chest.
1965;
48
408-415
-
150
Cruz J C, Diaz C, Marticorena E, Hilario V.
Phlebotomy improves pulmonary gas exchange in chronic mountain polycythemia.
Respiration.
1979;
38
305-313
-
151
Dinakara P, Blumenthal W S, Johnston R F, Kauffman L A, Solnick P B.
The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation.
Am Rev Respir Dis.
1970;
102
965-969
-
152
Heller P G, Grinberg A R, Lencioni M, Molina M M, Roncoroni A J.
Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria.
Chest.
1992;
102
642-643
-
153
Scadding J W.
Fibrosing alveolitis with autoimmune haemolytic anaemia: two case reports.
Thorax.
1977;
32
134-139
-
154
Jison M L, Gladwin M T.
Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.
Am J Respir Crit Care Med.
2003;
168
3-4
-
155
Perel Y, Dhermy D, Carrere A et al..
Portal vein thrombosis after splenectomy for hereditary stomatocytosis in childhood.
Eur J Pediatr.
1999;
158
628-630
-
156
Stewart G W, Amess J A, Eber S W et al..
Thrombo-embolic disease after splenectomy for hereditary stomatocytosis.
Br J Haematol.
1996;
93
303-310
Udaya B.S PrakashM.D.
Department of Pulmonary and Critical Care Medicine, East-18, Mayo Bldg., Mayo Medical Center, Rochester, MN 55905
Email: prakash.udaya@mayo.edu
